MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
TARA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Protara Therapeutics (TARA) Ownership - Who owns Protara Therapeutics?

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
345 Park Avenue South
Phone
+1 646 844-0337
Employees
27
Web
http://www.protaratx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
230.72M
P/E Ratio
N/A
Total Cash
135.79M
Projected Growth
N/A
Total Debt
3.06M
Revenue
N/A
Risk (Beta)
1.13
Dividend Yield
N/A
Total Cash/Share
2.42
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
TARA
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for TARA
A.I. Advisor
published General Information

General Information

a clinical-stage company, which engages in developing treatments for rare and specialty diseases with significant unmet needs.

Industry Biotechnology

Profile
Details
Industry
N/A
Address
345 Park Avenue South
Phone
+1 646 844-0337
Employees
27
Web
http://www.protaratx.com